ag 1879 has been researched along with afimoxifene in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clagett, D; Fan, P; Haddad, B; Jordan, VC; Kim, HR; McDaniel, RE | 1 |
1 other study(ies) available for ag 1879 and afimoxifene
| Article | Year |
|---|---|
Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line, Tumor; DNA, Neoplasm; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Estrogens; Female; Humans; MAP Kinase Signaling System; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phosphatidylinositol 3-Kinases; Progesterone; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Tamoxifen | 2012 |